About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Active Not RecruitingPhase 1

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

A Pilot Study of Condensed Busulfan, Melphalan, and Fludarabine Conditioning Prior to Ex-vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation

NCT04098393•Memorial Sloan Kettering Cancer Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Hematologic Malignancies

Interventions

Busulfan 3.2 mg/kg/day

Fludarabine

+4 more

Locations

1

United States

Locations (1)

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Key Dates

Start Date

September 18, 2019

Primary Completion Date

September 1, 2026

Completion Date

September 1, 2026

Last Updated

June 29, 2025

Related Studies

RECRUITINGPhase 1

Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies

NCT05011422

Pediatric Hematologic Malignancies

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

NCT07285668

Hematologic Malignancies

RECRUITINGPhase 1

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

NCT06823167

Solid MalignanciesHematologic Malignancies

RECRUITINGPhase 1

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT07195916

Solid TumorsHematologic Malignancies

Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety

NCT07185503

Mucormycosis in Hematologic Malignancies

RECRUITINGPhase 1

A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies

NCT07113925

Advanced Hematologic Malignancies

View all related studies

Sponsors

Lead Sponsor

Memorial Sloan Kettering Cancer Center

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 29, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions